InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Stark declines to enhance Idenix’s record $2.5bn patent damages award

Michael Loney, New York


District of Delaware says additional sanction is not warranted in Idenix v Gilead “given that the result of that misconduct is a cure for a potentially-fatal disease afflicting millions of people around the world, and given that the jury's damages award is already the largest damages verdict ever returned in a patent trial”

The District of Delaware has denied Idenix’s request to enhance the damages of $2.54 it was awarded for Gilead infringing its patents related to Hepatitis C drugs, which was the largest ever patent damages award in the US. Idenix was...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Well done to all involved! #AIPPI2017 #CII https://t.co/q5PbWThHjf

Oct 17 2017 12:59 ·  reply ·  retweet ·  favourite
ManagingIP profile

Friends in high places? #AIPPI2017 https://t.co/YnqhCgqIrh

Oct 17 2017 12:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @andreabrewster3: This event is for all IP professionals, of all genders @TheCIPA @CITMAuk @ipfederation @ip_out @ManagingIP See you the…

Oct 17 2017 12:54 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements